Advertisement
The risk for adverse drug reactions may be higher for women

Gender Differences Seen in Adverse Drug Reactions

0
Differences found in reaction symptoms and types of drugs tied to adverse reactions
Following implementation of the Affordable Care Act

Unemployed Workers Less Likely to Be Uninsured Post-ACA

0
Following implementation of ACA, insurance rates decreased more in states with Medicaid expansion

Trump Picks Vaccine Mandate Critic Dr. Jay Bhattacharya to Head National Institutes of Health

0
By Ernie Mundell HealthDay Reporter WEDNESDAY, Nov. 27, 2024 (HealthDay News) -- President-elect Donald Trump has tapped Dr. Jay Bhattacharya, a Stanford health economist and...

Data Show Big Drop in Number of Americans in Medical Debt

0

Number of Americans with medical debt on their credit reports fell by 8.2 million from 2020 to 2022

Hundreds of people have been charged after health care fraud sweeps were made across the United States

Hundreds Arrested Nationwide for Medicare/Medicaid Fraud

0
Many arrested were alleged to be involved in scams focused on Medicare's drug benefit
Market competition levels are associated with changes in the price of generic drugs

Market Competition Linked to Change in Generic Drug Prices

0
Price change of −31.7 percent for quadropoly and 47.4 percent for monopoly

FDA Oversight of Clinical Trials Described as ‘Grossly Inadequate’

0

Article describes inadequate oversight relating to development of COVID-19 vaccines and predating the pandemic

In 2017

Worker Contribution to Health Benefits Up in 2017

0
Share of firms offering coverage, workers receiving coverage remained stable
A review of U.S. Food and Drug Administration inspection reports between 1998 and 2013 revealed 57 clinical trials in which regulators had uncovered violations serious enough to earn the agency's most severe classification -- "official action indicated

Research Misconduct ID’d by FDA Often Unreported in Literature

0
Only three of 78 published studies mentioned issues of concern uncovered by FDA
Delivery of antioxidants to the eye may be a therapeutic option for cataracts

Review Explores Challenges of Ocular Antioxidants for Cataracts

0
Prospects for future research include the use of nanotechnology to deliver antioxidants